Home  Sitemap  Contact 
Site Search:
   Home » News & Events »

Sign me up to receive Cara press releases:
Email*
First Name
Last Name
Organization
 
  News & Events

News

  1. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845, Shelton, CT, August 5th, 2008

  2. Cara Therapeutics Secures $12.3 Million In Series C Extension Financing, July 24th 2008

  3. Cara Therapeutics Announces Issuance of U.S. Patent Covering Second Generation Kappa Opioid Receptor Agonists, July 22nd 2008

  4. Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845 , Shelton, CT, April 28th, 2008 /PRNewswire-FirstCall

  5. Cara Therapeutics Secures $19 Million In Series C Financing Tarrytown, NY (PRNewswire-FirstCall), November 28th, 2006

  6. Tripos and Cara Therapeutics Announce Medicinal Chemistry Partnership; Alliance to Address Unmet Medical Needs in the Treatment of Pain and Inflammation ST. LOUIS & BUDE, England (BUSINESS WIRE), March 22nd, 2006

  7. Cara Therapeutics Announces Results of Phase 1 Clinical Trial of Novel Analgesic; CR665 Safe and Pharmacologically Active Tarrytown, NY, July 28th, 2005

  8. Cara Therapeutics Initiates Clinical Trial of Novel Pain Drug Candidate Tarrytown, NY, March 24th 2005



Events

  1. Cara Therapeutics Poster "Development of the Novel, Peripherally-Selective Kappa Opiod Agonist CR665 for the Treatment of Acute Pain" Presented at the IASP (International Association for the Study of Pain) Meeting, August 17, 2008

  2. Cara Therapeutics Poster "Pharmacological Profile of a Novel Series of CB2-Selective Agonists with Efficacy in Visceral, Inflammatory, and Neuropathic Pain" Presented at the IASP (International Association for the Study of Pain) Meeting, August 17, 2008

  3. Cara Therapeutics Poster "Preclinical Profile of CR845" Presented at the IASP (International Association for the Study of Pain) Meeting, August 17, 2008

  4. Cara Therapeutics Poster "Synthesis, SAR Evaluation and Molecular Modeling of Modified Phenanthridines: Novel and Selective CB2 Agonists" Presented at the ICRS (International Cannabinoid Research Society) Meeting, June 25, 2008


Website Links

  1. www.wallstreetreporter.com
  2. www.curenet.org
  3. www.biospace.com
  4. www.ferring.com